Kitov Pharmaceuticals Hldgs L Sponsored ADR (KTOV)

[ash111]

"The FDA has approved the Phase III clinical trial design for KIT-302, in a Special
Protocol Assessment, in accordance with the shortened regulatory pathway,
Section 505(b)(2)"
http://www.in-pharmatechnologist.com/Regulatory-Safety/Kitov-saves-time-and-money?utm_source=RSS_text_news&utm_medium=RSS_feed&utm_campaign=RSS_Text_News

KTOV plans a marketing approval in 2017.